Summary

Persistence Market Research has recently released a comprehensive report on the global Peripheral Stent Implants Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Peripheral Stent Implants Market Size (2024E): USD 4.1 Bn
• Projected Market Value (2033F): USD 7.5 Bn
• Global Market Growth Rate (CAGR 2024 to 2033): 6.9%

Peripheral Stent Implants Market - Report Scope:

Peripheral stent implants are essential medical devices used to open narrowed or blocked arteries in the peripheral vascular system, such as in the legs, arms, and other areas outside the heart. These stents restore proper blood flow, preventing severe complications like limb ischemia. The market for peripheral stent implants is driven by the increasing prevalence of peripheral artery disease (PAD), advancements in stent technology, and rising demand for minimally invasive procedures. The report covers various types of stents, including bare-metal stents, drug-eluting stents, and bioresorbable stents, as well as their applications across different patient demographics.

Market Growth Drivers:

The global peripheral stent implants market is propelled by several factors, including the rising incidence of PAD, which is linked to an aging population, diabetes, and lifestyle-related risk factors. Technological advancements, such as the development of drug-eluting stents and bioresorbable scaffolds, are improving treatment outcomes and driving market growth. Additionally, the growing preference for minimally invasive procedures, which offer shorter recovery times and lower complication rates, is boosting the adoption of stent implants. Government initiatives and healthcare policies aimed at improving vascular health also contribute to market expansion.

Market Restraints:

Despite strong growth prospects, the peripheral stent implants market faces challenges related to high costs and reimbursement issues. The advanced technology in modern stents often results in higher prices, which can be a barrier for patients and healthcare providers, particularly in emerging economies. Furthermore, complications such as restenosis and stent thrombosis present clinical challenges that may limit market growth. Regulatory hurdles and the need for extensive clinical data to support new product approvals also pose challenges for market participants.

Market Opportunities:

The peripheral stent implants market offers significant growth opportunities driven by ongoing research and development, increasing awareness of vascular diseases, and expanding healthcare infrastructure in emerging markets. The development of next-generation stents with improved biocompatibility, flexibility, and drug-delivery capabilities presents potential for enhanced treatment outcomes. Market players can leverage these opportunities by investing in innovation, forming strategic partnerships with healthcare providers, and focusing on patient-centric product development. The growing trend toward personalized medicine and the adoption of advanced imaging technologies also provide avenues for market growth.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the peripheral stent implants market globally? • Which types of stents and technologies are leading in adoption across different patient demographics? • How are technological advancements influencing the competitive landscape of the peripheral stent implants market? • Who are the key players contributing to the peripheral stent implants market, and what strategies are they employing to maintain market relevance? • What are the emerging trends and future prospects in the global peripheral stent implants market?

Competitive Intelligence and Business Strategy:

Leading players in the global peripheral stent implants market, including Boston Scientific Corporation, Abbott Laboratories, and Medtronic plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to create advanced stent solutions, such as drug-eluting stents and bioresorbable scaffolds, tailored to diverse clinical needs and regulatory standards. Collaborations with healthcare providers, research institutions, and regulatory bodies facilitate market access and promote technology adoption. Emphasizing clinical outcomes, patient safety, and cost-effectiveness are key strategies driving market growth and reinforcing the position of leading players in the evolving vascular treatment landscape.

Key Companies Profiled:

• Abbott Laboratories
• B. Braun Melsungen AG
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cook Medical, Inc.
• Cardinal Health, Inc.
• iVascular SLU
• Medtronic Plc.
• Terumo Corporation
• W. L. Gore & Associates Inc.

Key Segments Covered in Peripheral Stent Implants Industry Research

Product:

• Bare Metal Stents (BMS)
• Covered Stents
• Drug-Eluting Stents (DES)

Artery:

• Carotid Artery Stents
• Fem-Pop Artery Stents
• Iliac Artery Stents
• Infrapop Artery Stents

End User:

• Hospitals
• Ambulatory Surgical Centers/Outpatient

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends
4. Key Success Factors
4.1. Key Promotional Strategies, by Manufacturers
4.2. Key Regulations
4.3. PESTEL Analysis
4.4. Porter’s Analysis
4.5. Product Launch Activities
4.6. Product Adoption/Usage Analysis
4.7. Reimbursement
4.8. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Peripheral Vascular Devices Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. New Product Launches and Approvals
5.2.3. Global Peripheral Vascular Diseases
5.2.4. Research and Development Expenditure by Key Players
5.2.5. Historic and Current Revenue of Key Players
5.2.6. Rising Consumer Awareness of the Product
5.2.7. Rising Adoption of Device Technological Development
5.2.8. Strategic Developments by Key Players
5.2.9. Increasing Adoption of Peripheral Vascular Devices for Various Arteries
5.2.10. Strategic Collaborations among Players
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Artery
6.1.3. By End User
6.1.4. By Country
6.2. 2024 Market Scenario
7. Global Market Volume (‘000 Units) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Volume (‘000 Units) Analysis, 2019-2023
7.2. Current and Future Market Volume (‘000 Units) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Material
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
9.1. Historical Market Value (US$ Bn) and Volume (‘000 Units) Analysis, 2019-2023
9.2. Current and Future Market Size (US$ Bn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) and Volume (‘000 Units) Analysis by Product, 2019-2023
10.3. Current and Future Market Size (US$ Bn) and Volume (‘000 Units) Analysis and Forecast by Product, 2024-2033
10.3.1. Bare Metal Stents (BMS)
10.3.2. Covered Stents
10.3.3. Drug Eluting Stents (DES)
10.4. Market Attractiveness Analysis by Product
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Artery
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis by Artery, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Artery, 2024-2033
11.3.1. Carotid Artery Stents
11.3.2. Fem-Pop Artery Stents
11.3.3. Iliac Artery Stents
11.3.4. Infrapop Artery Stents
11.4. Market Attractiveness Analysis by Artery
12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Bn) Analysis by End User, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by End User, 2024-2033
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers/Outpatients
12.4. Market Attractiveness Analysis by End User
13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Bn) and Volume (‘000 Units) Analysis, by Region, 2019-2023
13.3. Current and Future Market Size (US$ Bn) and Volume (‘000 Units) Analysis Forecast by Region, 2024-2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East & Africa
13.4. Market Attractiveness Analysis by Region
14. North America Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Bn) and Volume (‘000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Bn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Artery
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Artery
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. U.S. Market
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Artery
14.8.1.2.3. By End User
14.8.2. Canada Market
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Artery
14.8.2.2.3. By End User
15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Bn) and Volume (‘000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Bn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. Mexico
15.3.1.2. Brazil
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Artery
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Artery
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. Mexico Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Artery
15.8.1.2.3. By End User
15.8.2. Brazil Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Artery
15.8.2.2.3. By End User
15.8.3. Argentina Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Artery
15.8.3.2.3. By End User
16. Europe Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Bn) and Volume (‘000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Bn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Artery
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Artery
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Germany Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Artery
16.8.1.2.3. By End User
16.8.2. Italy Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Artery
16.8.2.2.3. By End User
16.8.3. France Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Artery
16.8.3.2.3. By End User
16.8.4. U.K. Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Artery
16.8.4.2.3. By End User
16.8.5. Spain Market Analysis
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast by Market Taxonomy
16.8.5.2.1. By Product
16.8.5.2.2. By Artery
16.8.5.2.3. By End User
16.8.6. BENELUX Market Analysis
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast by Market Taxonomy
16.8.6.2.1. By Product
16.8.6.2.2. By Artery
16.8.6.2.3. By End User
16.8.7. Russia Market Analysis
16.8.7.1. Introduction
16.8.7.2. Market Analysis and Forecast by Market Taxonomy
16.8.7.2.1. By Product
16.8.7.2.2. By Artery
16.8.7.2.3. By End User
17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Bn) and Volume (‘000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Bn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Artery
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Artery
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. China Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Artery
17.8.1.2.3. By End User
17.8.2. Japan Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Artery
17.8.2.2.3. By End User
17.8.3. South Korea Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Artery
17.8.3.2.3. By End User
18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Bn) and Volume (‘000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Bn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Indonesia
18.3.1.3. Malaysia
18.3.1.4. Thailand
18.3.1.5. Rest of South Asia
18.3.2. By Product
18.3.3. By Artery
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Artery
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. India Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Artery
18.8.1.2.3. By End User
18.8.2. Indonesia Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Artery
18.8.2.2.3. By End User
18.8.3. Malaysia Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Artery
18.8.3.2.3. By End User
18.8.4. Thailand Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Artery
18.8.4.2.3. By End User
19. Oceania Market 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Historical Market Size (US$ Bn) and Volume (‘000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Size (US$ Bn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Artery
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Artery
19.4.4. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. Australia Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Artery
19.8.1.2.3. By End User
19.8.2. New Zealand Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Artery
19.8.2.2.3. By End User
20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033
20.1. Introduction
20.2. Historical Market Size (US$ Bn) and Volume (‘000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
20.3. Current and Future Market Size (US$ Bn) and Volume (‘000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Türkiye
20.3.1.3. North Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Artery
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Artery
20.4.4. By End User
20.5. Market Trends
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
20.8. Country Level Analysis & Forecast
20.8.1. GCC Countries Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Artery
20.8.1.2.3. By End User
20.8.1.3. Türkiye Market Analysis
20.8.1.4. Introduction
20.8.1.5. Market Analysis and Forecast by Market Taxonomy
20.8.1.5.1. By Product
20.8.1.5.2. By Artery
20.8.1.5.3. By End User
20.8.2. South Africa Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Artery
20.8.2.2.3. By End User
20.8.3. North Africa Market Analysis
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast by Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By Artery
20.8.3.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Abbott Laboratories
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. Key Financials
22.3.1.5. SWOT Analysis
22.3.1.6. Key Developments
22.3.1.7. Strategy Overview
22.3.1.7.1. Marketing Strategy
22.3.1.7.2. Product Strategy
22.3.1.7.3. Channel Strategy
22.3.2. B. Braun Melsungen AG
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. Key Financials
22.3.2.5. SWOT Analysis
22.3.2.6. Key Developments
22.3.2.7. Strategy Overview
22.3.2.7.1. Marketing Strategy
22.3.2.7.2. Product Strategy
22.3.2.7.3. Channel Strategy
22.3.3. Biotronik SE & Co. KG
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. Key Financials
22.3.3.5. SWOT Analysis
22.3.3.6. Key Developments
22.3.3.7. Strategy Overview
22.3.3.7.1. Marketing Strategy
22.3.3.7.2. Product Strategy
22.3.3.7.3. Channel Strategy
22.3.4. Boston Scientific Corporation
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. Key Financials
22.3.4.5. SWOT Analysis
22.3.4.6. Key Developments
22.3.4.7. Strategy Overview
22.3.4.7.1. Marketing Strategy
22.3.4.7.2. Product Strategy
22.3.4.7.3. Channel Strategy
22.3.5. Cook Medical, Inc.
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. Key Financials
22.3.5.5. SWOT Analysis
22.3.5.6. Key Developments
22.3.5.7. Strategy Overview
22.3.5.7.1. Marketing Strategy
22.3.5.7.2. Product Strategy
22.3.5.7.3. Channel Strategy
22.3.6. Cardinal Health, Inc.
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. Key Financials
22.3.6.5. SWOT Analysis
22.3.6.6. Key Developments
22.3.6.7. Strategy Overview
22.3.6.7.1. Marketing Strategy
22.3.6.7.2. Product Strategy
22.3.6.7.3. Channel Strategy
22.3.7. iVascular SLU
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. Key Financials
22.3.7.5. SWOT Analysis
22.3.7.6. Key Developments
22.3.7.7. Strategy Overview
22.3.7.7.1. Marketing Strategy
22.3.7.7.2. Product Strategy
22.3.7.7.3. Channel Strategy
22.3.8. Medtronic Plc.
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. Key Financials
22.3.8.5. SWOT Analysis
22.3.8.6. Key Developments
22.3.8.7. Strategy Overview
22.3.8.7.1. Marketing Strategy
22.3.8.7.2. Product Strategy
22.3.8.7.3. Channel Strategy
22.3.9. Terumo Corporation
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. Key Financials
22.3.9.5. SWOT Analysis
22.3.9.6. Key Developments
22.3.9.7. Strategy Overview
22.3.9.7.1. Marketing Strategy
22.3.9.7.2. Product Strategy
22.3.9.7.3. Channel Strategy
22.3.10. W. L. Gore & Associates Inc.
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. Key Financials
22.3.10.5. SWOT Analysis
22.3.10.6. Key Developments
22.3.10.7. Strategy Overview
22.3.10.7.1. Marketing Strategy
22.3.10.7.2. Product Strategy
22.3.10.7.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology